Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Drug Metabolism Reviews | journal | 1.003 Q1 | 108 | 22 | 88 | 2608 | 623 | 88 | 6.27 | 118.55 | 44.54 | |
52 | Expert Review of Neurotherapeutics | journal | 0.995 Q1 | 98 | 85 | 343 | 7990 | 1417 | 304 | 3.81 | 94.00 | 41.81 | |
53 | HIV Medicine | journal | 0.989 Q1 | 86 | 138 | 312 | 4543 | 841 | 282 | 2.81 | 32.92 | 53.19 | |
54 | Recent advances in inflammation & allergy drug discovery | journal | 0.973 | 37 | 15 | 44 | 896 | 252 | 39 | 2.59 | 59.73 | 32.76 | |
55 | EJNMMI Radiopharmacy and Chemistry | journal | 0.972 Q1 | 28 | 33 | 97 | 1487 | 488 | 92 | 4.50 | 45.06 | 29.70 | |
56 | Pharmacotherapy | journal | 0.968 Q1 | 126 | 89 | 342 | 3530 | 1513 | 306 | 4.21 | 39.66 | 45.26 | |
57 | Investigational New Drugs | journal | 0.943 Q1 | 97 | 148 | 507 | 4426 | 1803 | 506 | 3.64 | 29.91 | 34.60 | |
58 | British Journal of Clinical Pharmacology | journal | 0.941 Q1 | 167 | 532 | 1075 | 22774 | 3615 | 910 | 3.25 | 42.81 | 44.85 | |
59 | Inflammopharmacology | journal | 0.932 Q1 | 68 | 188 | 379 | 12130 | 1989 | 367 | 5.27 | 64.52 | 44.07 | |
60 | World Journal of Men?s Health | journal | 0.920 Q1 | 29 | 66 | 205 | 2777 | 1031 | 191 | 4.53 | 42.08 | 22.19 | |
61 | Cardiovascular Drugs and Therapy | journal | 0.913 Q1 | 79 | 141 | 285 | 6791 | 1025 | 253 | 3.77 | 48.16 | 35.28 | |
62 | Clinical Therapeutics | journal | 0.896 Q1 | 150 | 154 | 679 | 6192 | 1958 | 590 | 2.75 | 40.21 | 42.79 | |
63 | Annals of Pharmacotherapy | journal | 0.891 Q1 | 122 | 184 | 505 | 4880 | 1476 | 399 | 2.98 | 26.52 | 52.64 | |
64 | Expert Opinion on Emerging Drugs | journal | 0.891 Q1 | 54 | 35 | 96 | 3238 | 316 | 90 | 3.40 | 92.51 | 36.54 | |
65 | Breast Cancer | journal | 0.882 Q1 | 66 | 107 | 370 | 3915 | 1209 | 359 | 3.39 | 36.59 | 42.19 | |
66 | Expert Review of Clinical Pharmacology | journal | 0.871 Q1 | 60 | 125 | 373 | 9993 | 1529 | 338 | 4.24 | 79.94 | 41.42 | |
67 | Drugs and Aging | journal | 0.865 Q1 | 109 | 78 | 283 | 4961 | 985 | 271 | 2.60 | 63.60 | 51.37 | |
68 | Contemporary Clinical Trials | journal | 0.847 Q1 | 75 | 278 | 656 | 12756 | 1495 | 645 | 2.23 | 45.88 | 58.88 | |
69 | American Journal of Cardiovascular Drugs | journal | 0.841 Q2 | 60 | 63 | 177 | 2606 | 543 | 168 | 3.26 | 41.37 | 29.88 | |
70 | Expert Review of Anticancer Therapy | journal | 0.841 Q2 | 85 | 125 | 346 | 9386 | 1087 | 306 | 2.84 | 75.09 | 39.72 | |
71 | Infection and Drug Resistance | journal | 0.840 Q2 | 65 | 724 | 1399 | 27329 | 6112 | 1383 | 4.13 | 37.75 | 43.59 | |
72 | OncoTargets and Therapy | journal | 0.836 Q2 | 86 | 131 | 2593 | 6691 | 10334 | 2590 | 3.89 | 51.08 | 42.32 | |
73 | Pharmaceutical Statistics | journal | 0.832 Q2 | 46 | 94 | 228 | 2875 | 306 | 211 | 1.41 | 30.59 | 32.43 | |
74 | Infection and Chemotherapy | journal | 0.831 Q2 | 38 | 94 | 209 | 2902 | 712 | 193 | 3.76 | 30.87 | 47.48 | |
75 | Paediatric Drugs | journal | 0.818 Q2 | 70 | 58 | 148 | 4262 | 622 | 142 | 4.13 | 73.48 | 54.15 | |
76 | Cancer Drug Resistance | journal | 0.815 Q2 | 24 | 72 | 222 | 6487 | 821 | 218 | 3.35 | 90.10 | 48.48 | |
77 | Trials | journal | 0.814 Q2 | 98 | 1030 | 2718 | 41630 | 6431 | 2565 | 2.24 | 40.42 | 49.27 | |
78 | Cancer Chemotherapy and Pharmacology | journal | 0.811 Q2 | 122 | 129 | 624 | 4183 | 1952 | 614 | 2.94 | 32.43 | 42.91 | |
79 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.800 Q2 | 13 | 17 | 41 | 972 | 137 | 37 | 2.87 | 57.18 | 45.24 | |
80 | Vascular Health and Risk Management | journal | 0.798 Q2 | 82 | 86 | 189 | 3714 | 807 | 188 | 2.93 | 43.19 | 35.49 | |
81 | Cannabis and Cannabinoid Research | journal | 0.797 Q2 | 42 | 96 | 130 | 4627 | 553 | 122 | 4.28 | 48.20 | 46.64 | |
82 | Antibiotics | journal | 0.792 Q2 | 77 | 1838 | 2748 | 110359 | 14048 | 2708 | 5.04 | 60.04 | 48.45 | |
83 | Cardiovascular Therapeutics | journal | 0.790 Q2 | 54 | 67 | 124 | 3211 | 463 | 124 | 3.09 | 47.93 | 40.63 | |
84 | Therapeutic Advances in Cardiovascular Disease | journal | 0.784 Q2 | 41 | 13 | 47 | 643 | 175 | 43 | 2.37 | 49.46 | 33.78 | |
85 | Journal of Experimental Pharmacology | journal | 0.778 Q2 | 23 | 31 | 138 | 1572 | 563 | 137 | 4.25 | 50.71 | 28.93 | |
86 | Topics in antiviral medicine | journal | 0.778 Q2 | 46 | 13 | 45 | 330 | 110 | 42 | 0.87 | 25.38 | 38.24 | |
87 | Pulmonary Pharmacology and Therapeutics | journal | 0.776 Q2 | 81 | 40 | 213 | 1825 | 741 | 208 | 3.19 | 45.63 | 39.29 | |
88 | Journal of Child and Adolescent Psychopharmacology | journal | 0.774 Q2 | 92 | 73 | 300 | 2366 | 590 | 233 | 1.57 | 32.41 | 55.10 | |
89 | Expert Opinion on Drug Safety | journal | 0.773 Q2 | 90 | 143 | 414 | 9964 | 1467 | 384 | 3.19 | 69.68 | 42.42 | |
90 | AIDS Research and Therapy | journal | 0.740 Q2 | 49 | 69 | 205 | 2803 | 520 | 205 | 2.25 | 40.62 | 49.85 | |
91 | Clinical Psychopharmacology and Neuroscience | journal | 0.740 Q2 | 42 | 84 | 231 | 3840 | 610 | 223 | 2.66 | 45.71 | 37.13 | |
92 | Journal of Cardiovascular Development and Disease | journal | 0.725 Q2 | 32 | 462 | 284 | 24006 | 899 | 281 | 2.47 | 51.96 | 37.42 | |
93 | European Journal of Clinical Pharmacology | journal | 0.723 Q2 | 123 | 211 | 615 | 7457 | 1545 | 521 | 2.48 | 35.34 | 45.97 | |
94 | Journal of Biopharmaceutical Statistics | journal | 0.721 Q2 | 56 | 66 | 222 | 1892 | 235 | 208 | 0.93 | 28.67 | 40.00 | |
95 | Experimental and Clinical Psychopharmacology | journal | 0.718 Q2 | 101 | 104 | 276 | 5904 | 736 | 274 | 2.15 | 56.77 | 54.82 | |
96 | Therapeutic Advances in Drug Safety | journal | 0.715 Q2 | 46 | 34 | 97 | 1643 | 352 | 82 | 3.71 | 48.32 | 53.85 | |
97 | Medical Cannabis and Cannabinoids | journal | 0.713 Q2 | 13 | 16 | 38 | 725 | 164 | 32 | 4.20 | 45.31 | 34.67 | |
98 | Expert Opinion on Pharmacotherapy | journal | 0.702 Q2 | 93 | 203 | 693 | 15953 | 2053 | 596 | 2.71 | 78.59 | 40.47 | |
99 | Journal of Clinical Pharmacology | journal | 0.691 Q2 | 130 | 178 | 564 | 7307 | 1587 | 522 | 2.74 | 41.05 | 42.60 | |
100 | Drug Target Insights | journal | 0.690 Q2 | 16 | 13 | 15 | 522 | 62 | 14 | 2.90 | 40.15 | 36.54 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®